ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,155.72
-0.60%
Dow Jones
40,287.53
-0.93%
Gold vs US Dollar
2,400.775
0.00%
Brent Oil
81.875
0.00%
Bitcoin
66,619.59
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Alterity Therapeutics Ltd (PK) (PRNAF)

  7. Alterity Therapeutics Ltd (PK) (PRNAF) News

Alterity Therapeutics (PK) (PRNAF)

Alterity Therapeutics Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PRNAF
DateTimeSourceHeadlineSymbolCompany
19/07/202411:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/07/202411:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/07/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
17/07/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
15/07/202411:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/03/202413:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/03/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
20/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
06/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/12/202313:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
11/12/202311:38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/12/202311:39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
30/11/202302:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
29/11/202311:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
27/11/202311:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202313:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202313:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202312:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202312:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/11/202312:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
20/11/202313:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/10/202310:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
30/10/202312:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/10/202313:44Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersUSOTC:PRNAFAlterity Therapeutics Ltd (PK)
 Showing the most relevant articles for your search:USOTC:PRNAF

Your Recent History

LSE
GDR
Genedrive
LSE
ONDO
Ondo Insurtech
LSE
DGE
Diageo
LSE
ENET
Ethernity Networks
LSE
MIN
Minoan
LSE
SCE
Surface Transforms
LSE
SOLG
Solgold
LSE
SCLP
Scancell
LSE
ENT
Entain
LSE
ATM
Andrada Mining
LSE
PREM
Premier African Minerals
LSE
SRSP
Sirius Petroleum
LSE
AXL
Arrow Exploration
LSE
JSE
Jadestone Energy
LSE
HUM
Hummingbird Resources
LSE
PIC
Pace Plc
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved